Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
The Delaware Supreme Court has agreed to hear an appeal by GSK and other drugmakers, including Pfizer, Sanofi, and Boehringer Ingelheim, to dismiss over 70,000 lawsuits. These lawsuits claim that the discontinued heartburn drug Zantac caused cancer. The appeal seeks to overturn a lower court's decision that allows plaintiffs to present expert testimony on the alleged cancer link. The court's decision to review the case has led to a rise in GSK's share prices.
In key win for GSK, Delaware court will review decision to allow expert testimony in Zantac cases https://t.co/jodlNCpUU5
GSK, Pfizer, Sanofi and Boehringer Ingelheim are asking Delaware's top court to overturn a lower court order allowing plaintiffs in more than 70,000 Zantac lawsuits to offer expert testimony on the drug's alleged cancer link https://t.co/zkhpoeLaGR https://t.co/48CmfCYdJy
Delaware's highest court will hear an appeal by GSK and other drugmakers seeing to end lawsuits claiming Zantac caused cancer. https://t.co/zoekbKoHlF
